Literature DB >> 15884090

Effects of sertraline on depressive symptoms and attentional and executive functions in major depression.

Eric L Constant1, Stéphane Adam, Benoît Gillain, Xavier Seron, Raymond Bruyer, Arlette Seghers.   

Abstract

Reports on the severity and reversibility of cognitive disturbances in major depression in the literature diverge due to methodological biases. The present study, using a precise methodology, examined attention and executive functions in 20 relatively young, depressed patients presenting a first or second episode of unipolar major depression without psychotic or melancholic characteristics and all being treated with the same psychopharmacological treatment (sertraline) to investigate the changes in potential attentional and executive loss during a subacute period of treatment of 7 weeks. We compared their performance with a group of 26 control subjects who were administered the same cognitive tests. This study confirmed psychomotor slowing associated with attentional and executive disturbance in adults with major depression. Conscious attentional interference for words with a negative emotional valence also was shown. After the first weeks of treatment, the effect of the antidepressant treatment with sertraline was accompanied by a beneficial effect on psychomotor slowing on attentional and executive functions. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15884090     DOI: 10.1002/da.20060

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  15 in total

Review 1.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 2.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

3.  Neurocognitive Functioning in Depressed Young People: A Systematic Review and Meta-Analysis.

Authors:  Joanne Goodall; Caroline Fisher; Sarah Hetrick; Lisa Phillips; Emma M Parrish; Kelly Allott
Journal:  Neuropsychol Rev       Date:  2018-04-22       Impact factor: 7.444

4.  Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.

Authors:  Marianne Gorlyn; John Keilp; Ainsley Burke; Maria Oquendo; J John Mann; Michael Grunebaum
Journal:  Psychiatry Res       Date:  2014-12-13       Impact factor: 3.222

5.  Psychomotor speed: possibly a new marker for overtraining syndrome.

Authors:  Esther Nederhof; Koen A P M Lemmink; Chris Visscher; Romain Meeusen; Theo Mulder
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

6.  Subjective perception of cognition is related to mood and not performance.

Authors:  S E Marino; K J Meador; D W Loring; M S Okun; H H Fernandez; A J Fessler; R P Kustra; J M Miller; P G Ray; A Roy; M R Schoenberg; V J Vahle; M A Werz
Journal:  Epilepsy Behav       Date:  2009-01-06       Impact factor: 2.937

7.  Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).

Authors:  Stephanie Collins Reed; Frances R Levin; Suzette M Evans
Journal:  Horm Behav       Date:  2008-03-07       Impact factor: 3.587

8.  Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task.

Authors:  Yia-Ping Liu; Yu-Lung Lin; Chia-Hsin Chuang; Yu-Cheng Kao; Shang-Tang Chang; Che-Se Tung
Journal:  J Biomed Sci       Date:  2009-08-14       Impact factor: 8.410

Review 9.  Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.

Authors:  Raymond W Lam; Sidney H Kennedy; Roger S Mclntyre; Atul Khullar
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 10.  Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning.

Authors:  Krzysztof Krysta; Marek Krzystanek; Małgorzata Janas-Kozik; Adam Klasik; Irena Krupka-Matuszczyk
Journal:  J Neural Transm (Vienna)       Date:  2014-07-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.